A detailed history of Tower Research Capital LLC (Trc) transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,049 shares of PRME stock, worth $23,342. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,049
Previous 5,157 56.08%
Holding current value
$23,342
Previous $26,000 19.23%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.41 - $6.7 $9,861 - $19,376
2,892 Added 56.08%
8,049 $31,000
Q2 2024

Aug 13, 2024

SELL
$4.3 - $8.03 $8,195 - $15,305
-1,906 Reduced 26.99%
5,157 $26,000
Q1 2024

May 15, 2024

SELL
$6.35 - $9.39 $88,569 - $130,971
-13,948 Reduced 66.38%
7,063 $49,000
Q4 2023

Feb 13, 2024

BUY
$5.59 - $9.55 $97,729 - $166,962
17,483 Added 495.55%
21,011 $186,000
Q3 2023

Nov 14, 2023

BUY
$9.5 - $15.07 $3,657 - $5,801
385 Added 12.25%
3,528 $33,000
Q2 2023

Aug 14, 2023

SELL
$11.41 - $17.05 $935 - $1,398
-82 Reduced 2.54%
3,143 $46,000
Q1 2023

May 09, 2023

BUY
$11.21 - $21.11 $31,970 - $60,205
2,852 Added 764.61%
3,225 $40,000
Q4 2022

Feb 10, 2023

BUY
$15.2 - $21.12 $5,669 - $7,877
373 New
373 $7,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $278M
More about PRME
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.